FMP
Sensus Healthcare, Inc.
SRTS
NASDAQ
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
4.65 USD
0.22 (4.73%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
92.11M
114.75M
80.91M
63.49M
65.85M
62.11M
58.59M
55.26M
52.12M
49.16M
-
24.58
-29.49
-21.53
3.73
-5.68
-5.68
-5.68
-5.68
70.83M
93.21M
54.81M
35.91M
-
35.09M
33.09M
31.22M
29.44M
27.77M
76.9
81.23
67.74
56.57
-
56.49
56.49
56.49
56.49
70.13M
92.67M
54.31M
35.23M
-750k
34.58M
32.62M
30.77M
29.02M
27.37M
76.14
80.76
67.13
55.49
-1.14
55.68
55.68
55.68
55.68
703k
543k
494k
685k
750k
504.97k
476.29k
449.24k
423.72k
399.66k
0.76
0.47
0.61
1.08
1.14
0.81
0.81
0.81
0.81
EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)